Reports from Dialysis Clinic Inc. Describe Recent Advances in Kidney Diseases and Conditions (Medication Reconciliation: the Foundation of Medication Safety for Patients Requiring Dialysis)

2020 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Kidney Diseases and Conditions have been published. According to news reporting out of Nashville, Tennessee, by NewsRx editors, research stated, “Medication-related problems are a leading cause of morbidity and mortality. Patients requiring dialysis are at heightened risk for adverse drug reactions because of the prevalence of polypharmacy, multiple chronic conditions, and altered (but not well understood) medication pharmacokinetics and pharmacodynamics inherent to kidney failure.”

Funders for this research include National Institute on Aging, American Society of Nephrology Foundation for Kidney Research, Doris Duke Charitable Foundation.

Our news journalists obtained a quote from the research from Dialysis Clinic Inc., “To minimize preventable medication-related problems, health care providers need to prioritize medication safety for this population. The cornerstone of medication safety is medication reconciliation. We present a case highlighting adverse outcomes when medication reconciliation is insufficient at care transitions. We review available literature on the prevalence of medication discrepancies worldwide. We also explain effective medication reconciliation and the practical considerations for implementation of effective medication reconciliation in dialysis units. In light of the addition of medication reconciliation requirements to the Centers for Medicare & Medicaid Services End-Stage Renal Disease Quality Incentive Program, this review also provides guidance to dialysis unit leadership for improving current medication reconciliation practices.”

According to the news editors, the research concluded: “Prioritization of medication reconciliation has the potential to positively affect rates of medication-related problems, as well as medication adherence, health care costs, and quality of life.”

This research has been peer-reviewed.

For more information on this research see: Medication Reconciliation: the Foundation of Medication Safety for Patients Requiring Dialysis. American Journal of Kidney Diseases, 2020;76(6):868-876. American Journal of Kidney Diseases can be contacted at: W B Saunders Co-Elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA. (Elsevier - www.elsevier.com; American Journal of Kidney Diseases - http://www.journals.elsevier.com/american-journal-of-kidney-diseases/)

Our news journalists report that additional information may be obtained by contacting Harold J. Manley, Dialysis Clinic Inc., Nashville, TN, United States. Additional authors for this research include Jill Frament and Rasheeda K. Hall.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1053/j.ajkd.2020.07.021. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)